Jointly provided by Partners for Advancing Clinical Education (PACE) and Ig National Society, Inc.
Original Release Date: May 13, 2024
Expiration Date: May 13, 2025
Target Audience
This activity is intended for pharmacists and nurses who care for patients with Kawasaki disease.
Educational Objectives
Upon completion of this activity, participants should be able to:
- Explain the role of IgE and Th2 immunity for protection of the fetus and the mother during the pregnancy, and preparation of the post-partum baby for anti-parasitic protection, and subsequent antibody production
- Discuss the role of IgE and Mast cells in allergic disease, usurped from their role for anti-parasitic protection
- Distinguish True Allergic Disease from Pseudo-Allergic Manifestations
Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by Partners for Advancing Clinical Education (PACE) and Ig National Society, Inc. PACE is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Nursing Continuing Professional Development
The maximum number of hours awarded for this Nursing Continuing Professional Development activity is 1.0 contact hours.
Pharmacy Continuing Education
PACE designates this continuing education activity for 1.0 contact hour(s) (0.075 CEUs) of the Accreditation Council for Pharmacy Education.
(Universal Activity Number – JA4008073-9999-24-117-H01-P)
Type of Activity: Knowledge
Faculty & Disclosures
PACE requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated according to PACE policies. Others involved in the planning of this activity have no relevant financial relationships.
Faculty
Terry O Harville, MD, PhD, D(ABMLI), F(ACHI) Professor of Pathology and Laboratory Medicine, and Internal Medicine
University of Arkansas for Medical Sciences
Department of Pathology and Laboratory Medicine, and Internal Medicine, Division of Hematology and Oncology
Laboratories of Histocompatibility, Immunogenetics, and Transplantation
Little Rock, AR
Faculty Conflicts of Interest
Has no relevant financial relationships.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
Instructions for Credit
Participation in this self-study activity should be completed in 1.0 hour. To successfully complete activities and receive CE credit, learners must follow these steps:
- Review the objectives and disclosures
- Study the educational content
- Complete the activity evaluation
- Upon completion of all evaluation questions your credit will be made available for download immediately.
For Pharmacists: Upon completing the online evaluation, your credit will be submitted to CPE Monitor. Please check your NABP account within thirty (30) days to make sure the credit has posted.
For additional information about the accreditation of this activity, please visit https://partnersed.com.